RNA-based stable isotope probing provides no indication for rapid α-synuclein assimilation by murine gut bacteria

References

1. Perez-Pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J et al. The gut-brain axis in Parkinson’s disease: Possibilities for food-based therapies. Eur J Pharmacol 2017; 817:86–95 [View Article] [PubMed]
   [Google Scholar]
2. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s Disease. Curr Treat Options Neurol 2018; 20:54 [View Article] [PubMed]
   [Google Scholar]
3. Lang AE. A critical appraisal of the premotor symptoms of Parkinson’s disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 2011; 26:775–783 [View Article] [PubMed]
   [Google Scholar]
4. Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE et al. Medical records documentation of constipation preceding Parkinson disease: A case-control study. Neurology 2009; 73:1752–1758 [View Article] [PubMed]
   [Google Scholar]
5. Nair AT, Ramachandran V, Joghee NM, Antony S, Ramalingam G. Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson’s disease: a critical review. J Neurogastroenterol Motil 2018; 24:30–42 [View Article] [PubMed]
   [Google Scholar]
6. Rocha EM, De Miranda B, Sanders LH. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease. Neurobiol Dis 2018; 109:249–257 [View Article] [PubMed]
   [Google Scholar]
7. Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?. NPJ Parkinsons Dis 2017; 3:3 [View Article] [PubMed]
   [Google Scholar]
8. Gold A, Turkalp ZT, Munoz DG. Enteric alpha-synuclein expression is increased in Parkinson’s disease but not Alzheimer’s disease. Mov Disord 2013; 28:237–240 [View Article] [PubMed]
   [Google Scholar]
9. Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases. Mov Disord 2012; 27:716–719 [View Article] [PubMed]
   [Google Scholar]
10. Hilton D, Stephens M, Kirk L, Edwards P, Potter R et al. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease. Acta Neuropathol 2014; 127:235–241 [View Article] [PubMed]
    [Google Scholar]
11. Braak H, de Vos RAI, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 2006; 396:67–72 [View Article] [PubMed]
    [Google Scholar]
12. Gries M, Christmann A, Schulte S, Weyland M, Rommel S et al. Parkinson mice show functional and molecular changes in the gut long before motoric disease onset. Mol Neurodegener 2021; 16:34 [View Article] [PubMed]
    [Google Scholar]
13. Paillusson S, Clairembault T, Biraud M, Neunlist M, Derkinderen P. Activity-dependent secretion of alpha-synuclein by enteric neurons. J Neurochem 2013; 125:512–517 [View Article] [PubMed]
    [Google Scholar]
14. Weis S, Schwiertz A, Unger MM, Becker A, Faßbender K et al. Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiota. NPJ Parkinsons Dis 2019; 5:28 [View Article] [PubMed]
    [Google Scholar]
15. Unger MM, Spiegel J, Dillmann K-U, Grundmann D, Philippeit H et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls. Parkinsonism Relat Disord 2016; 32:66–72 [View Article] [PubMed]
    [Google Scholar]
16. Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR et al. Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome. Mov Disord 2017; 32:739–749 [View Article] [PubMed]
    [Google Scholar]
17. Scheperjans F, Aho V, Pereira PAB, Koskinen K, Paulin L et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord 2015; 30:350–358 [View Article] [PubMed]
    [Google Scholar]
18. Li W, Wu X, Hu X, Wang T, Liang S et al. Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features. Sci China Life Sci 2017; 60:1223–1233 [View Article] [PubMed]
    [Google Scholar]
19. Hopfner F, Künstner A, Müller SH, Künzel S, Zeuner KE et al. Gut microbiota in Parkinson disease in a northern German cohort. Brain Res 2017; 1667:41–45 [View Article] [PubMed]
    [Google Scholar]
20. Berry D, Loy A. Stable-isotope probing of human and animal microbiome function. Trends Microbiol 2018; 26:999–1007 [View Article] [PubMed]
    [Google Scholar]
21. Lueders T, Dumont MG, Bradford L, Manefield M. RNA-stable isotope probing: from carbon flow within key microbiota to targeted transcriptomes. Curr Opin Biotechnol 2016; 41:83–89 [View Article]
    [Google Scholar]
22. Weis S, Schnell S, Egert M. RNA-based stable isotope probing (RNA-SIP) in the gut environment. Methods Mol Biol 2019; 2046:221–231 [View Article]
    [Google Scholar]
23. Egert M, Weis S, Schnell S. RNA-based stable isotope probing (RNA-SIP) to unravel intestinal host-microbe interactions. Methods 2018; 149:25–30 [View Article]
    [Google Scholar]
24. Smith HO, Levine M. Two sequential repressions of DNA synthesis in the establishment of lysogeny by phage P22 and its mutants. Proc Natl Acad Sci U S A 1964; 52:356–363 [View Article]
    [Google Scholar]
25. Herrmann E, Young W, Rosendale D, Conrad R, Riedel CU et al. Determination of resistant starch assimilating bacteria in fecal samples of mice by in vitro RNA-based stable isotope probing. Front Microbiol 2017; 8:1331 [View Article]
    [Google Scholar]
26. Lane DJ. 16S/23S rRNA sequencing. In Stackebrandt E, Goodfellow M. eds Molecular Microbiological Methods: Nucleic Acid Techniques in Bacterial Systematics New York: Wiley; 1991 pp 115–175
    [Google Scholar]
27. Lane DJ, Pace B, Olsen GJ, Stahl DA, Sogin ML et al. Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses. Proc Natl Acad Sci U S A 1985; 82:6955–6959 [View Article] [PubMed]
    [Google Scholar]
28. Herrmann E, Young W, Rosendale D, Reichert-Grimm V, Riedel CU et al. RNA-based stable isotope probing suggests Allobaculum spp. as particularly active glucose assimilators in a complex murine microbiota cultured in vitro. Biomed Res Int 2017; 2017:1829685 [View Article]
    [Google Scholar]
29. Young W, Egert M, Bassett SA, Bibiloni R. Detection of sialic acid-utilising bacteria in a caecal community batch culture using RNA-based stable isotope probing. Nutrients 2015; 7:2109–2124 [View Article] [PubMed]
    [Google Scholar]
30. Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F et al. Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis 2021; 7:27 [View Article] [PubMed]
    [Google Scholar]
31. Egert M, de Graaf AA, Maathuis A, de Waard P, Plugge CM et al. Identification of glucose-fermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing. FEMS Microbiol Ecol 2007; 60:126–135 [View Article] [PubMed]
    [Google Scholar]
32. Whiteley AS, Thomson B, Lueders T, Manefield M. RNA stable-isotope probing. Nat Protoc 2007; 2:838–844 [View Article] [PubMed]
    [Google Scholar]
33. Herrmann E, Young W, Reichert-Grimm V, Weis S, Riedel CU et al. In vivo assessment of resistant starch degradation by the caecal microbiota of mice using RNA-based stable isotope probing-a proof-of-principle study. Nutrients 2018; 10:E179 [View Article] [PubMed]
    [Google Scholar]
34. Enggrob KL, Larsen T, Peixoto L, Rasmussen J. Gram-positive bacteria control the rapid anabolism of protein-sized soil organic nitrogen compounds questioning the present paradigm. Sci Rep 2020; 10:15840 [View Article] [PubMed]
    [Google Scholar]
35. Jehmlich N, Vogt C, Lünsmann V, Richnow HH, von Bergen M. Protein-SIP in environmental studies. Curr Opin Biotechnol 2016; 41:26–33 [View Article] [PubMed]
    [Google Scholar]